HIV Infections
Conditions
Brief summary
Despite the widespread availability of effective antiretroviral therapy (ART) in the United States, there remains significant numbers of people living with HIV (PLWH) who fail to achieve and or maintain viral suppression (VS). Disparities persist with the lowest levels of VS among Black individuals, people who use drugs, youth ages 18-24 and people residing in rural areas. Investigators will examine the syndemics underlying these outcomes including substance use, mental health, and barriers to HIV care including racial discrimination, stigma and rural isolation.
Detailed description
This study will follow a digital cohort via the REMAIN App. The REMAIN App is adapted from the HealthMPowerment (HMP) platform and tailored to our focus population's unique needs. Digital cohorts, or eCohorts, utilize the flexibility and capacity of the internet to complement traditional approaches to epidemiological research, helping address some of the limitations and challenges associated with conventional cohort studies. Aim 1 of this study is to recruit and retain a geographically and demographically diverse cohort of PLWH who are sub optimally engaged in care and with a history of, at high risk for, or not currently virally suppressed. Outcomes for this are levels of recruitment and retention to hit the study objectives to enroll 1,000 PLWH at risk for or experiencing VNS and follow them for up to 48 months. Aim 2 is to evaluate longitudinal patterns of care engagement within the cohort by modeling and advanced epidemiologic methods utilizing remote collection of biomarkers of HIV disease (e.g., viral load), online surveys, and brief, frequent app-based check-ins. Outcomes include both those related to VS and engagement in care as well as engagement in the digital cohort.
Interventions
OTHEREPI LOVE
Observational cohort only
Sponsors
Florida State University
University of California, Irvine
University of North Carolina, Chapel Hill
AIDS Healthcare Foundation
National Institute of Allergy and Infectious Diseases (NIAID)
University of California, Los Angeles
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE
Masking description
N/A - all participants get the app
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Have access to a personal smartphone device; * Over 18 years of age; * Speak English or Spanish; * Living with HIV * Are either 1) not currently virally suppressed, 2) not currently engaged in care, or 3) have one or more factors associated with viral non suppression including a history of missed appointments or viral non suppression; * Active substance use or mental health disorder; * Willing and able to provide written informed consent to take part in the study.
Exclusion criteria
* Unwilling or unable to provide reliable contact information; * Unwilling to provide blood sample for HIV virology testing; * Living with HIV and virally suppressed and not at risk of becoming unsuppressed in the near future.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Incidence of HIV Viral Suppression | past 3 months | Suppression defined as having less than 200 copies of HIV per milliliter of blood. |
| Level of Adherence to HIV medication | past 6 months | Adherence of at least 80% to ARV medication |
| Level of Adherence based on HIV appointments | one year | Adherence defined as not missing more than 1 HIV care appointment in 1 year |
Countries
United States
Contacts
Primary ContactPamina Gorbach, DrPh
Backup ContactValerie El-Alfi, MA
Outcome results
None listed